EATONTOWN, N.J., Feb. 14, 2025 /PRNewswire/ -- Avertix Medical, Inc. ("Avertix" or the "Company"), the developer of The Guardian® system - the world's first real-time, continuous heart attack detection and patient alerting system today announced compelling new data confirming the...
Hence then, the article about avertix s guardian system confirmed as cost effective for high risk acute coronary syndrome patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Avertix's Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients )
Also on site :
- Cuban official accuses US of ‘piracy’ against sanctioned Caribbean island
- EU must stop funding Kiev after Zelensky’s ‘insults’ – Italian MP
- The One Florida Hotel Family Travel Advisors Book on Repeat—and It’s Not Disney